Array BioPharma Inc.
Array BioPharma Inc. Files Shelf Registration Statement
Published in Drug Law Weekly, November 25th, 2008
Array BioPharma Inc. (NASDAQ: ARRY) announced that it has filed a shelf registration statement on Form S-3 with the Securities and Exchange Commission (SEC). The shelf registration statement, when declared effective by the SEC, will allow the company to raise up to $150 million through the sale of securities, which may consist of common stock, preferred stock, depositary shares and/or warrants, in one or more offerings in the future. Specific terms and prices will be determined at the time of any offering and included in a prospectus supplement to be filed with the SEC relating to that offering.
A registration statement relating to the securities listed in the shelf...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2008-11-25)
More Articles from Drug Law Weekly
- 3M
3M ToughShield Sleeves Protect Against Theft of Personal Information - Accentia Biopharmaceuticals, Inc.
Accentia Biopharmaceuticals Announces Reorganization Plan to Maximize Long-Term Shareholder Value, Fully Pay All Creditors and Continue Operations to Commercialize Its Drug Portfolio - AngioDynamics Inc.
AngioDynamics to Launch VenaCure EVLT, New Brand for Varicose Vein Treatment - ArQule, Inc.
ArQule and Daiichi-Sankyo Enter Into Strategic R&D Partnership to Progress Novel Compounds to Target Cancer - Autism
Two Men Complete First-Ever Walk Across the Country for Autism - Diabetes
Patient Recruitment Begins in India for Phase 3 Diabetes Trial - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
